Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Color Diagnostics, |
RCV001804678 | SCV002051986 | uncertain significance | Cardiomyopathy | 2022-01-18 | criteria provided, single submitter | clinical testing | This variant replaces twenty-two nucleotides in exon 15 of the DSG2 gene with twelve new nucleotides, creating a frameshift in the last exon. The mutant transcript is expected to escape nonsense-mediated decay and be expressed as a protein product containing altered C-terminal sequence. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A truncating variant occurring downstream of this variant, c.3059_3062del (p.Glu1020Alafs*18), has been observed in individuals affected with arrhythmogenic right ventricular cardiomyopathy (ClinVar variation ID: 199827). Although there is a suspicion for a pathogenic role, clinical relevance of loss-of-function DSG2 truncation and splice variants in autosomal dominant arrhythmogenic right ventricular cardiomyopathy is not yet clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |